SCHEMBL26334498

SCHEMBL26334498

CCC(CC)COC(=O)[C@H](C)NCOCC(C#N)(OC)[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26345159 0.92 RIPK1 (0.31) —
SCHEMBL26345179 0.92 RIPK1 (0.31) —
SCHEMBL26334372 0.92 RIPK1 (0.31) —
SCHEMBL23818654 0.91 RIPK1 (0.30) —
SCHEMBL26333914 0.90 — —
SCHEMBL23818755 0.89 RIPK1 (0.31) —
SCHEMBL23819343 0.89 — —
SCHEMBL23818667 0.89 — —
SCHEMBL26333107 0.89 — —
SCHEMBL26333768 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
Send feedback